{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T20:39:23Z","timestamp":1780778363259,"version":"3.54.1"},"reference-count":31,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T00:00:00Z","timestamp":1556755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["374031971 \u2013 TRR 240\/Z2"],"award-info":[{"award-number":["374031971 \u2013 TRR 240\/Z2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Mathematical optimization framework allows the identification of certain nodes within a signaling network. In this work, we analyzed the complex extracellular-signal-regulated kinase 1 and 2 (ERK1\/2) cascade in cardiomyocytes using the framework to find efficient adjustment screws for this cascade that is important for cardiomyocyte survival and maladaptive heart muscle growth. We modeled optimal pharmacological intervention points that are beneficial for the heart, but avoid the occurrence of a maladaptive ERK1\/2 modification, the autophosphorylation of ERK at threonine 188 (ERK      Thr 188      phosphorylation), which causes cardiac hypertrophy. For this purpose, a network of a cardiomyocyte that was fitted to experimental data was equipped with external stimuli that model the pharmacological intervention points. Specifically, two situations were considered. In the first one, the cardiomyocyte was driven to a desired expression level with different treatment strategies. These strategies were quantified with respect to beneficial effects and maleficent side effects and then which one is the best treatment strategy was evaluated. In the second situation, it was shown how to model constitutively activated pathways and how to identify drug targets to obtain a desired activity level that is associated with a healthy state and in contrast to the maleficent expression pattern caused by the constitutively activated pathway. An implementation of the algorithms used for the calculations is also presented in this paper, which simplifies the application of the presented framework for drug targeting, optimal drug combinations and the systematic and automatic search for pharmacological intervention points. The codes were designed such that they can be combined with any mathematical model given by ordinary differential equations.<\/jats:p>","DOI":"10.3390\/ijms20092179","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T03:15:46Z","timestamp":1557198946000},"page":"2179","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["How to Steer and Control ERK and the ERK Signaling Cascade Exemplified by Looking at Cardiac Insufficiency"],"prefix":"10.3390","volume":"20","author":[{"given":"Tim","family":"Breitenbach","sequence":"first","affiliation":[{"name":"Biozentrum, Universit\u00e4t W\u00fcrzburg, Am Hubland, 97074 W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Lorenz","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology and Toxicology, Versbacher Stra\u00dfe 9, 97078 W\u00fcrzburg, Germany"},{"name":"Leibniz-Institut f\u00fcr Analytische Wissenschaften-ISAS-e.V., 44139 Dortmund, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1886-7625","authenticated-orcid":false,"given":"Thomas","family":"Dandekar","sequence":"additional","affiliation":[{"name":"Biozentrum, Universit\u00e4t W\u00fcrzburg, Am Hubland, 97074 W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,5,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.biocel.2009.08.002","article-title":"Cardiac hypertrophy: Targeting Raf\/MEK\/ERK1\/2-signaling","volume":"41","author":"Lorenz","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2009.05088.x","article-title":"Extracellular signal-regulated kinase 1\/2 (ERK1\/2) signaling in cardiac hypertrophy","volume":"1188","author":"Kehat","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","article-title":"Mitogen-activated protein kinase signaling in the heart: Angels versus demons in a heart-breaking tale","volume":"90","author":"Rose","year":"2010","journal-title":"Physiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/cvr\/cvs249","article-title":"\u03b2-Adrenergic receptor stimulation causes cardiac hypertrophy via a G\u03b2\u03b3\/ERK-dependent pathway","volume":"96","author":"Vidal","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm.1893","article-title":"A new type of ERK1\/2 autophosphorylation causes cardiac hypertrophy","volume":"15","author":"Lorenz","year":"2009","journal-title":"Nat. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"7440","DOI":"10.1073\/pnas.1221999110","article-title":"Interference with ERKThr188 phosphorylation impairs pathological but not physiological cardiac hypertrophy","volume":"110","author":"Ruppert","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.molcel.2008.08.007","article-title":"Identification and characterization of a general nuclear translocation signal in signaling proteins","volume":"31","author":"Chuderland","year":"2008","journal-title":"Mol. Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/nsmb.1656","article-title":"Phosphoproteomics reveals new ERK MAP kinase targets and links ERK to nucleoporin-mediated nuclear transport","volume":"16","author":"Kosako","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1515\/BC.2005.133","article-title":"B-Raf and C-Raf signaling investigated in a simplified model of the mitogenic kinase cascade","volume":"386","author":"Robubi","year":"2005","journal-title":"Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Sz\u00e1sz, I., Koroknai, V., Kiss, T., V\u00edzkeleti, L., \u00c1d\u00e1ny, R., and Bal\u00e1zs, M. (2019). Molecular alterations associated with acquired resistance to BRAFV600E targeted therapy in melanoma cells. Melanoma Res.","DOI":"10.1097\/CMR.0000000000000588"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phrs.2019.01.039","article-title":"Targeting ERK1\/2 protein-serine\/threonine kinases in human cancers","volume":"142","author":"Roskoski","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1097-2765(02)00528-2","article-title":"Mathematical models of protein kinase signal transduction","volume":"9","author":"Heinrich","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nm.3972","article-title":"Cardiac RKIP induces a beneficial \u03b2-adrenoceptor\u2013dependent positive inotropy","volume":"21","author":"Schmid","year":"2015","journal-title":"Nat. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1039\/C6MB00255B","article-title":"Analyzing ERK 1\/2 signalling and targets","volume":"12","author":"Brietz","year":"2016","journal-title":"Mol. BioSyst."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Karl, S., and Dandekar, T. (2013). Jimena: Efficient computing and system state identification for genetic regulatory networks. BMC Bioinform., 14.","DOI":"10.1186\/1471-2105-14-306"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Di Cara, A., Garg, A., De Micheli, G., Xenarios, I., and Mendoza, L. (2007). Dynamic simulation of regulatory networks using SQUAD. BMC Bioinform., 8.","DOI":"10.1186\/1471-2105-8-462"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/bioinformatics\/btn350","article-title":"Dynamical modeling and multi-experiment fitting with PottersWheel","volume":"24","author":"Maiwald","year":"2008","journal-title":"Bioinformatics"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Breitenbach, T., Liang, C., and Dandekar, T. (2019). Analyzing pharmacological intervention points: A method to calculate external stimuli to switch between steady states in regulatory networks, In press.","DOI":"10.1371\/journal.pcbi.1007075"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/1878-0261.12323","article-title":"A combined tissue-engineered\/in silico signature tool patient stratification in lung cancer","volume":"12","author":"Kunz","year":"2018","journal-title":"Mol. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1593\/neo.05553","article-title":"Construction of a novel constitutively active chimeric EGFR to identify new targets for therapy","volume":"7","author":"Cheng","year":"2005","journal-title":"Neoplasia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.bbrc.2008.12.146","article-title":"Constitutively active Erythropoietin receptor expression in breast cancer cells promotes cellular proliferation and migration through a MAP-kinase dependent pathway","volume":"379","author":"Fu","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1158\/1535-7163.MCT-06-0078","article-title":"Constitutively active receptor tyrosine kinases as oncogenes in preclinical models for cancer therapeutics","volume":"5","author":"Kellar","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"ref_23","first-page":"319","article-title":"The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis","volume":"37","author":"Yim","year":"2005","journal-title":"Cancer Res. Treat. Off. J. Korean Cancer Assoc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/rmv.1738","article-title":"Genome guardian p53 and viral infections","volume":"23","author":"Sato","year":"2013","journal-title":"Rev. Med Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1101\/gad.1456306","article-title":"Crystal structure of SV40 large T-antigen bound to p53: Interplay between a viral oncoprotein and a cellular tumor suppressor","volume":"20","author":"Lilyestrom","year":"2006","journal-title":"Genes Dev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijcard.2018.05.068","article-title":"Extracellular signal-regulated kinase (ERK) activation preserves cardiac function in pressure overload induced hypertrophy","volume":"270","author":"Mutlak","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Bohush, A., Niewiadomska, G., and Filipek, A. (2018). Role of mitogen activated protein kinase signaling in parkinson\u2019s disease. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19102973"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2119\/molmed.2011.00512","article-title":"Signaling to cardiac hypertrophy: Insights from human and mouse RASopathies","volume":"18","author":"Sala","year":"2012","journal-title":"Mol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12064-010-0112-x","article-title":"A robust model to describe the differentiation of T-helper cells","volume":"129","author":"Mendoza","year":"2010","journal-title":"Theory Biosci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1038\/leu.2017.41","article-title":"Frequency of regulatory T cells determines the outcome of the T-cell-engaging antibody blinatumomab in patients with B-precursor ALL","volume":"31","author":"Duell","year":"2017","journal-title":"Leukemia"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Philippi, N., Walter, D., Schlatter, R., Ferreira, K., Ederer, M., Sawodny, O., Timmer, J., Borner, C., and Dandekar, T. (2009). Modeling system states in liver cells: Survival, apoptosis and their modifications in response to viral infection. BMC Syst. Biol., 3.","DOI":"10.1186\/1752-0509-3-97"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/9\/2179\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:48:45Z","timestamp":1760186925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/9\/2179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,2]]},"references-count":31,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,5]]}},"alternative-id":["ijms20092179"],"URL":"https:\/\/doi.org\/10.3390\/ijms20092179","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,2]]}}}